Evaxion Biotech A/S (NASDAQ:EVAX) Q2 2025 Earnings Call Transcript August 19, 2025
Operator: Hello, and welcome to Evaxion’s Second Quarter 2025 Conference Call. [Operator Instructions] I would now like to turn the conference over to Birgitte Rono, Interim CEO and CSO. You may begin.
Birgitte Rono: Thank you for that. So first and foremost, welcome to our Q2 2025 business update and financial results. I am Birgitte Rono, Chief Scientific Officer and Interim CEO of Evaxion. And with me today,...
